For instance, sourcing often depends on a limited pool of suppliers, making it vulnerable to disruptions caused by geopolitical instability or unforeseen shortages. In manufacturing, companies must strike a balance between cost efficiency and maintaining rigorous quality standards. Packaging plays a critical role in ensuring product safety, traceability, and regulatory compliance. Warehousing demands tight control of temperature and inventory, especially for drugs that require specific storage conditions. The distribution stage faces particular difficulties in achieving timely and cost-effective last-mile delivery, particularly in remote or underserved areas. Across all these stages, accurate demand forecasting is crucial to prevent both shortages and excess inventory, ensuring a consistent and reliable supply of essential medicines. 

Given the interdependence of the different supply chain stages, a lack of coordination or transparency in one part can affect the entire system. Siloed systems and fragmented data hinder the ability to respond quickly to changes or emerging risks. End to end visibility, powered by real-time data, enables proactive identification of issues such as supplier delays or quality defects before they escalate. It supports continuous monitoring of transport and storage conditions, ensuring compliance with safety standards. Better inventory alignment with actual demand helps prevent waste and ensures availability. In the case of recalls, visibility allows for rapid identification and removal of affected batches, enhancing patient safety and regulatory compliance. To achieve this level of visibility, many pharmaceutical companies are increasingly adopting integrated digital platforms that centralize data from suppliers, manufacturers, and distributors².